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 ABSTRACT 
The present study aimed to synthesize and characterize dehydrozingerone as well 
as to investigate its anticonvulsant activity in experimental animals.  A simple 
method was used to synthesize dehydrozingerone using vanillin and acetone. The 
synthesized drug dehydrozingerone was characterized using thin layer 
chromatography (TLC), high performance liquid chromatography (HPLC), 
infrared spectroscopy (IR) and physicochemical tests.The synthesized product 
was  tested for its potential anticonvulsant activity using maximum electroshock 
(MES) induced seizure models in rats. The synthesized dehydrozingerone showed 
TLC profile, FT IR spectra and HPLC chromatogram similar to the authentic 
sample. The physicochemical characters (colour, taste, flavour, solubility and 
melting point) were also similar to what was found in the literature. All these 
results indicated that the produced product was dehydrozingerone. A dose 
dependent anticonvulsant activity was produced by dehydrozingerone. Eighty 
percent anti-MES activity was presented by 100 mg/kg.  The findings indicated 
that dehydrozingerone represents a bioactive molecule possessing anticonvulsant 
activity. In addition, it is an easily synthesized compound from cheap starting 
materials. In conclusion dehydrozingerone may find its place as antiepileptic 
agent if further clinical studies will be conducted. 
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INTRODUCTION 
Dehydrozingerone is a pungent constituent present in the rhizomes of 
ginger (Zingiber officinale) and belongs structurally to the vanillyl ketone 
class (Yogosawa et al., 2012). Dehydrozingerone is reported to possess 
many biological activities such as: antioxidant (Kuo et al., 2005), 
antitumor (Motohashi et al., 1998), inhibitory effect on vascular smooth 
muscle cell function(Yizhen et al., 2008) and antifungal(Kubra et al., 
2012) activities. The present study aimed to synthesize and characterize 
dehydrozingerone as well as to investigate its anticonvulsant activity in 
experimental animals. 
 
Dehydrozingerone 
Product category               
: 
Aromatic ketone 
Molecular formula            
: 
C11H12O3 
Molecular weight              
: 
192.2
Melting point                    
: 
125-130 °C 
Boiling point                     
: 
348.2 °C
Synonyms                         
: 
Dehydrogingerone 
Dehydro[0]-paradol 
Feruloylmethane 
3-Methoxy-4-hydroxybenzalacetone 
4-(4-hydroxy-3-methoxyphenyl)-3-buten-2-one 
4-hydroxy-3-methoxystyrylmethylketone 
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MATERIALS AND METHODS 
MATERIALS 
Chemicals:  
Pentylentetrazole, dehydrozingerone and vanillin were purchased from 
Sigma-Aldrich, UK, acetone, hydrochloric acid, ethanol, sodium hydroxide 
and tween20 were obtained from Loba Chemie, India. 
METHODS 
 
Preparation of working solutions of chemicals: 
 
Freshly prepared solutions of pentylentetrazole dissolved in normal saline 
and dehydrozingerone dissolved in 5% tween20 were used. 
 
Experimental animals:  
 
Albino rats of both sexes weighing 150 – 200 g were used. The animals 
were kept and maintained under appropriate laboratory conditions, allowed 
free access to water and fasted for an over night before the experiment. 
Synthesis of dehydrozingerone: 
Vanillin (4g) was placed in a beaker. Acetone (20 ml) and 10% sodium 
hydroxide solution (20 ml) were added to vanillin. The mixture was stirred, 
stoppered and allowed to stand for 48 hours. After standing, the dark 
colored mixture is acidified with 10% hydrochloric acid (60 ml), placed in 
an ice bath and stirred. Upon acidification and stirring a yellowish-brown 
solid was formed. The solid material was filtered and washed several times 
with cold water. The crude product was recrystallized from 50% aqueous 
ethanol (Allen et al., 2006). 
Identification of dehydrozingerone: 
Melting point determination: 
 
The melting point of the synthetic dehydrozingerone was determined in 
sealed capillary tubes on an electrothermal melting point apparatus (Veego 
Scientific MP-D. India). Results were the mean of triplicate readings. 
Thin layer chromatography (TLC) for synthetic dehydrozingerone: 
The synthesized dehydrozingerone and the standard reference were 
chromatographed on TLC sheet, silica gel 60 of thickness 0.2mm (Riedel-
de Haen AG. Seelze Germany) using toluene and ethyl acetate (93: 7) as 
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solvent system. Iodine vapoure was used as locating agent. Rf values were 
calculated.  
 
Infrared spectroscopy (FT IR) for synthetic dehydrozingerone: 
 
IR spectra of both synthesized and reference dehydrozingerone were 
recorded on FTIR spectrophotometer-8400 S (Shimadzu-Japan), using KBr 
disk of IR spectroscopic grade (Shimadzu Laboratory reagents, Japan). 
High performance liquid chromatography (HPLC) for synthetic 
dehydrozingerone: 
 
The synthesized dehydrozingerone and the standard reference were 
analyzed by high performance liquid chromatography (Waters, USA) 
equipped with Shim-pack VP-ODS column C18 (250* 4.6 mm). Isocratic 
elution was performed using a mixture of HPLC grade methanol and water 
(65:35 v/v), flow rate 1.0ml/min, temperature 28๐C. Photodiode Array 
Detector was set at 280nm. Sample injection volume was 20 μl. 
Maximal electroshock-induced seizure test: 
 
Maximal electroshock (MES) seizure model was used to evaluate the 
anticonvulsant activity of dehydrozingerone. Seizures were induced in rats 
by delivering electroshock of 50 mA for 0.5 second by means of an 
electro- convulsiometer (Ugobasile ECT unit 57800) through a pair of ear 
clip electrodes (Kumar et al., 2008). Six groups of rats of both sexes were 
used. Three groups of rats (n=5) received dehydrozingerone (10, 50 and 
100 mg/kg) intraperitoneally (i.p) (Manigauha et al., 2009). Thirty minutes 
later rats were tested for MES induced seizure response. Two groups of 
rats (n=3) received sodium valporoate (300 and 400 mg/kg) injected i.p. 
and tested after 15 minutes for MES induced seizure response. All the 
experimental groups were compared to a control group administered the 
vehicle (tween20).  
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RESULTS AND DISCUSSION 
 
Synthesis and identification of dehydrozingerone (DZ): 
 
Literature reports showed an easy method for dehydrozingerone 
(C11H12O3) synthesis, in which two starting materials, vanillin and acetone 
were, used (Allen et al., 2006). .  
 
 
 
 
Fig. 1: Synthesis of dehydrozingerone. 
 
The reactions produced fragrant, brilliant yellow powder of good yield 
(1.99 g; 50%). The powder is soluble in alcohol and insoluble in water. 
Melting point was determined as being 126-127 °C. Results obtained agree 
with what has been reported by Allen et al., (2006). The conducted DZ 
synthetic method produced a considerable yield of the product in lower 
number of steps. TLC profiles (Fig. 2), HPLC chromatograms (Fig. 3) and 
FT IR spectra (Fig. 4) of the synthesized dehydrozingerone (SDZ) are 
almost matching with those obtained from dehydrozingerone (DZ) 
standard sample. For TLC, identical Rf value (0.2) was observed using 
iodine vapour as locating agent whereas HPLC analysis revealed similar 
retention time (1.32 minute).   
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FT IR spectra represents bands at 3303 (broad band), 3001, 2948, 2848, 
2362, 1676, 1637, 1581, 1517, 1452, 1425, 1367, 1298, 1263, 1224, 1166, 
1122, 1024, 979, 937, 875, 821, 804, 756, 671, 576, 543, and 464 cm
-1
.  
The characteristic and diagnostic bands of dehydrozingerone are visible in 
the region (3303-1581 cm
–1
). All the literature (Hatzade et al., 2009; 
Hatzade et al., 2008; Dudley and Fleming, 1980) agrees in assigning a 
band at 3303 cm
–1 
to the stretching of O-H bond. Two characteristic aryl 
C-H stretching bands also appeared at 3001 cm
-1 
and 2362 cm
-1
. Aliphatic 
C-H stretching appeared at 2948 and 2848 cm
-1
. Carbonyl conjugated 
double bond stretching was represented by a band at 1676 cm
-1
. Aromatic 
C=C stretching appeared at 1637cm
-1
 and 1581cm
-1
. In addition the 
overcrowded lower IR fingerprint region of dehydrozingerone, where 
many absorption bands occur was found to be identical to the reference 
sample, presenting band at 1224 cm
–1
 for phenolic O-H bending and aryl 
alkyl ether of characteristic two peaks; asymmetric   C-O-C stretch at 1263 
cm
-1
 and a symmetric stretch at 1024cm
-1
.  
The analytical data obtained and physicochemical characters (colour, taste, 
flavour, solubility and melting point), TLC profile, FT IR spectrum and 
HPLC chromatogram for the SDZ coincide with those of the reference 
sample as well as they match with data shown in the literature confirming 
that the synthesized compound was indeed dehydrozingerone . 
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   Fig.2: TLC chromatogram of (a): synthesized dehydrozingerone 
                            (b): reference dehydrozingerone. 
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Fig. 3: HPLC chromatogram of (A) Reference dehydrozingerone (B) 
Synthetic dehydrozingerone. 
 A) 
 
B) 
 
Fig.4: FTIR spectra of (A) Reference dehydrozingerone (B) synthetic  
           dehydrozingerone. 
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Anticonvulsant activity of the synthesized dehydrozingerone: 
As shown in Table 1 dehydrozingerone produced a dose dependent 
anticonvulsant activity in the maximum electroshocks seizure model used. 
High doses were required to prevent seizure induced by MES. Eighty 
percent anti-MES activity was presented by 100mg/kg. There was no 
previous reported data about the anticonvulsant activity of 
dehydrozingerone. Dehydrozingerone presents a reactive molecule 
containing vanillyl aromatic moiety, conjugated double bond system, 
reactive carbonyl group and capability of hydrogen bonding, all that may 
contribute to its anticonvulsant activity.  
 
Table 1: Anti-maximum electroshocks (MES) activity of the synthetic    
dehydrozingerone . 
Treatment Vehicle 
Sodium valporoate 
(standard) 
Dehydrozingerone 
Dose mg/kg 10ml/kg 300 400 10 50 100 
Seizure protection (%) 0.00 66.6 100 20 40 80 
 
CONCLUSIONS 
 
The findings indicated that dehydrozingerone represents a bioactive 
molecule possessing anticonvulsant activity. In addition, it is an easily 
synthesized compound from cheap starting materials. In conclusion 
dehydrozingerone may find its place as antiepileptic agent if further 
clinical studies are conducted. 
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